PL BioScience has advanced an oral BPC-157 formulation (designated PL-10) to Phase II clinical trials for inflammatory bowel disease representing the most clinically advanced human development of oral BPC-157 to date.3 Human peer-reviewed results from these trials are pending, but the preclinical rationale is strong
Glutathione may well be the most important intracellular defence against damage by reactive oxygen species
Semaglutide: The GLP-1 Pathway Semaglutide is a GLP-1 receptor agonist with 94% homology to native GLP-1 and a ~7-day half-life achieved through C18 fatty acid acylation and DPP-4 resistance (Muller et al., 2021)
Both sides make claims about skin tone, antioxidant protection, and that word everyone uses without defining it: "glow." The question worth answering is specific
Acknowledgements We are grateful to University College Dublin for providing plasma, serum and urine samples for this study
If visible rubber fragments appear in the vial contents after a draw, the documented standard is to discard the vial regardless of remaining volume or days left in the window
